Print Issue: November 01, 2011

Irwin Goldstein, MD

Investigational Drug Helps Diabetics with ED

LISBON—Avanafil, an investigational, highly specific phosphodiesterase type 5 inhibitor, is an effective treatment for erectile dysfunction (ED) in men with diabetes, according to phase 3 data released at the 47th European Association for the Study of Diabetes annual meeting.

Next post in Feature